BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 17098828)

  • 21. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
    Singh N; Joshi S; Guo L; Baker MB; Li Y; Castellano RK; Raizada MK; Jarajapu YP
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1697-707. PubMed ID: 26386115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chymase-dependent production of angiotensin II: an old enzyme in old hearts.
    Froogh G; Pinto JT; Le Y; Kandhi S; Aleligne Y; Huang A; Sun D
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H223-H231. PubMed ID: 27815252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
    Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
    PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.
    Giani JF; Muñoz MC; Mayer MA; Veiras LC; Arranz C; Taira CA; Turyn D; Toblli JE; Dominici FP
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1003-13. PubMed ID: 20061544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
    Fischer R; Dechend R; Gapelyuk A; Shagdarsuren E; Gruner K; Gruner A; Gratze P; Qadri F; Wellner M; Fiebeler A; Dietz R; Luft FC; Muller DN; Schirdewan A
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1242-53. PubMed ID: 17416596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats.
    Wang H; Jessup JA; Zhao Z; Da Silva J; Lin M; MacNamara LM; Ahmad S; Chappell MC; Ferrario CM; Groban L
    PLoS One; 2013; 8(10):e76992. PubMed ID: 24204720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.
    Pang XF; Zhang LH; Bai F; Wang NP; Garner RE; McKallip RJ; Zhao ZQ
    Drug Des Devel Ther; 2015; 9():6043-54. PubMed ID: 26648693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
    Zhang C; Li Y; Wang C; Wu Y; Du J
    Am J Hypertens; 2014 Jun; 27(6):857-64. PubMed ID: 24419904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
    Bürgelová M; Vanourková Z; Thumová M; Dvorák P; Opocenský M; Kramer HJ; Zelízko M; Malý J; Bader M; Cervenka L
    J Hypertens; 2009 Oct; 27(10):1988-2000. PubMed ID: 19593210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
    Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
    Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.
    Tallant EA; Ferrario CM; Gallagher PE
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1560-6. PubMed ID: 15951342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Pregabalin-Induced Cardiotoxicity in Rats: Mechanistic Role of Angiotensin 1-7.
    Awwad ZM; El-Ganainy SO; ElMallah AI; Khedr SM; Khattab MM; El-Khatib AS
    Cardiovasc Toxicol; 2020 Jun; 20(3):301-311. PubMed ID: 31720995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats.
    Sullivan JC; Bhatia K; Yamamoto T; Elmarakby AA
    Hypertension; 2010 Oct; 56(4):658-66. PubMed ID: 20713916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Keidar S; Kaplan M; Gamliel-Lazarovich A
    Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7).
    Peng WW; Hong L; Liu GY; Lin C; Zhao XL; Wang SZ; Lin L; Pan YX
    Hypertens Res; 2019 Nov; 42(11):1745-1756. PubMed ID: 31273339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
    Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
    Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.